Work

Abstract OT-13-08: A remote-directed “virtual” clinical trial in metastatic breast cancer to determine feasibility of evaluating patient response to immunotherapy using spliceosome mutational markers (SF3B1): The PRISMM trial (NCT04447651)

Year: 2021

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs20-ot-13-08

Authors: Natasha Hunter, Jeffrey Wang, Leslie Cope, Christine Hodgdon, Vered Stearns, Elizabeth Jaffee, Ben Park, Cesar A Santa-Maria

Institutions: University of Washington, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Vanderbilt University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3131671634

Cites:

Cited by:

Related to: 10